[1]
Mishra, S. et al. 2018. SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA. International Journal of Applied Pharmaceutics. 10, 5 (Sep. 2018), 117–124. DOI:https://doi.org/10.22159/ijap.2018v10i5.27597.